obesity patiennts
Conditions
Interventions
Sponsors
HEC Science Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria:
Exclusion criteria
Exclusion criteria: 1.Individuals who do not consent to participate in the study 2.Those whom the principal investigator or co-investigator determines are not suitable to participate in this clinical research 3.Women who are pregnant or may be pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Food Frequency Questionnaire (FFQ) and eating behavior assessments at 6 months before starting semaglutide, at the time of initiation, and at 6, 12, and 18 months after starting | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in body mass index Change in body weight Change in waist circumference Change in blood pressure Change in pulse rate Change in HbA1c Change in blood glucose level Change in LDL-Cholesterol Change in HDL-Cholesterol Change in triglycerides Change in Aspartate Aminotransferase Change in Alanine Aminotransferase Change in Gamma-Glutamyl Transferase Change in body fat mass Change in muscle mass Change in skeletal muscle mass Change in basal metabolic rate Change in average energy expenditure Change in average step count | — |
Countries
Japan
Contacts
Public ContactHajime Maeda
HEC Science Clinic Department of Diabetes
Outcome results
None listed